Among speculative small-cap biotechs, analyst calls are often accompanied with upside price targets of 50%, 100% or even 200%. This is because the companies are often all-in bets on one or two treatments.
Insiders havereappeared after being mostly in hibernation as first-quarter earnings results were reported by many of the major corporations in the United States over the past five weeks.
The windows for insiders to buy and sell stock sure look like they came flying open this week, as insiders at top companies dipped into their wallets and started buying stock big time.
24/7 Wall St. looks companies that completely blew out their earnings this past week. They are based on strong growth from the same quarter of last year, as well as a beat on what…
The sinkhole called the U.S. Postal Service lost another $1.3 billion in the first quarter, more evidence that the it needs to begin cutting costs aggressively now.
ThinkstockMay 8, 2015: Here are four stocks among the 46 equities making new 52-week lows today. MannKind Corp. (NASDAQ: MNKD) dropped more than 12% on Friday to post a new 52-week low of $3.52…
thinkstockMay 8, 2015: Markets opened higher on Friday after a solid report on jobs. The unemployment rate fell another tick to 5.4%. The election results in the U.K. were also a source of early…
InterCloud Systems is back at it again with a huge jump in shares Friday morning. It is no secret that InterCloud shares have been known to be very volatile.